Stocks · News reference
Mizuho Maintains Underperform on Fluence Energy, Lowers Price Target to $6
Mizuho analyst Maheep Mandloi maintains Fluence Energy (NASDAQ:FLNC) with a Underperform and lowers the price target from $8 to $6.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
FLNC or BE: Which Alternative Energy Stock Is Worth Buying Now?
In a comparison of two alternate energy stocks, Bloom Energy (BE) emerges as the more attractive investment despite Fluence Energy's (FLNC) lower valuation. BE benefits from stronger price performance, consistent earnings beats, and growing demand from AI data centers, while FLNC faces manufacturing delays, guidance cuts, and battery oversupply concerns.
Bloom Energy vs. Eos Energy Enterprises: Which Energy Storage Stock Is a Better Buy in 2026?
The article compares two energy storage companies: Bloom Energy, a mature fuel cell provider with strong partnerships and profitability, and Eos Energy Enterprises, an emerging zinc-based battery manufacturer with explosive revenue growth but significant losses. Despite Bloom's higher valuation multiples, Eos is recommended for its attractive P/S ratio, recent business advances, and strong 2026 pipeline, while Bloom benefits from the AI datacenter boom with expected 85% revenue growth.
Fluence Energy (NASDAQ: FLNC) Faces Investor Scrutiny Amid Additional Surprises About Houston Facility -- HBSS
Fluence Energy (NASDAQ: FLNC) stock plummeted 15% on September 17, 2026, after revealing significant operational issues at its Houston manufacturing facility, including problems with automated welding processes and a shift to manual welding. The company also slashed 2026 revenue guidance by $600 million and fired its Chief Product Officer. Hagens Berman has launched an investigation into whether the company failed to adequately disclose these problems to investors.